The business magazine of the Südwestpresse featured our CEO Dr. Frank Mathias in their cover story this month. In his interview, he provided insights on Rentschler Biopharma, and what sets the company apart in today's dynamic CDMO landscape.
One contributing factor is the fact, that Rentschler Biopharma is a family-owned business. This structure of a mid-sized business offers flexibility in making agile decisions and establishing efficient processes. Simultaneously, it allows for sustainable, long-term planning with meaningful value creation. Thereby, Rentschler Biopharma benefits from the independence to plan for the future, while not exclusively focusing on short-term financial profit. Frank Mathias is convinced, that the consistent pursuit of a solid strategy will lead to financial success.
Learn more about the strategy and future plans of Rentschler Biopharma in the full interview here (German only).
Rentschler Biopharma SE
Dr. Cora Kaiser
Senior Director Corporate Communication